Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B-cell acute leukemia

Jo Ishizawa, Eiji Sugihara, Shinji Kuninaka, Kaoru Mogushi, Kensuke Kojima, Christopher B. Benton, Ran Zhao, Dhruv Chachad, Norisato Hashimoto, Rodrigo O. Jacamo, Yihua Qiu, Suk Young Yoo, Shinichiro Okamoto, Michael Andreeff, Steven M. Kornblau, Hideyuki Saya

Blood (2017) 129 (14): 1958–1968.

https://doi.org/10.1182/blood-2016-07-726216

Published: 2017

Includes: Supplemental data

Journal Articles

Recurrent Patterns of Protein Expression Signatures in Pediatric Acute Lymphoblastic Leukemia: Recognition and Therapeutic Guidance

Fieke W Hoff, Chenyue W Hu, Yihua Qiu, MD, Suk-Young Yoo, Amina Qutub, Terzah M. Horton, MD PhD, Steven M. Kornblau, MD

Blood (2016) 128 (22): 4089.

https://doi.org/10.1182/blood.V128.22.4089.4089

Published: 2016

Journal Articles

Recognition of Recurrent Protein Expression Patterns in Pediatric Acute Myeloid Leukemia Suggests New Therapeutic Targets

Fieke W Hoff, Chenyue W Hu, Yihua Qiu, MD, Suk-Young Yoo, Amina Qutub, Eveline S. de Bont, Terzah M. Horton, MD PhD, Steven M. Kornblau, MD

Blood (2016) 128 (22): 1712.

https://doi.org/10.1182/blood.V128.22.1712.1712

Published: 2016

Journal Articles

Functional Proteomic Profiling of Myelodysplastic Syndromes Reveals Distinct Protein Expression Signatures and Identifies Candidate Therapeutic Targets

Brittany Knick Ragon, MD, Fieke W Hoff, Chenyue W Hu, Yihua Qiu, MD, Suk-Young Yoo, Amina Qutub, Steven M. Kornblau, MD

Blood (2016) 128 (22): 1975.

https://doi.org/10.1182/blood.V128.22.1975.1975

Published: 2016

Journal Articles

Role of Mesenchymal Stem Cell Galectin 3 in the AML Tumor Microenvironment

Peter Ruvolo, PhD, Yihua Qiu, MD, Vivian Ruvolo, MS, Rui-Yu Wang, MD PhD, Zhihong Zeng, MD, Jared Burks, PhD, Rongqing Pan, MS, Numsen Hail, Jr., PhD, Teresa McQueen, Suk-Young Yoo, Steven M. Kornblau, MD, Michael Andreeff, MD PhD

Blood (2015) 126 (23): 1198.

https://doi.org/10.1182/blood.V126.23.1198.1198

Published: 2015

Journal Articles

Acute Myelogenous Leukemia (AML) Mesenchymal Stromal Cell (MSC) Have Distinct Protein Expression Patterns Compared to Normal MSC

Steven M. Kornblau, MD, Peter Ruvolo, PhD, Rui-Yu Wang, MD PhD, Vivian Ruvolo, MS, Yihua Qiu, MD, Venkata Lokesh Battula, PhD, Zhihong Zeng, MD, Teresa McQueen, Suk-Young Yoo, Marina Konopleva, MD PhD, Michael Andreeff, MD, PhD

Blood (2015) 126 (23): 3813.

https://doi.org/10.1182/blood.V126.23.3813.3813

Published: 2015

Journal Articles

Adhesion Signaling States in AML

Chenyue W Hu, Amina A Qutub, PhD, Yihua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Naval G. Daver, MD, Maro Ohanian, DO, Kevin Coombes, PhD, Steven M. Kornblau, MD

Blood (2014) 124 (21): 2386.

https://doi.org/10.1182/blood.V124.21.2386.2386

Published: 2014

Journal Articles

CREB/ATF Family Protein Expression States in AML: Active CREB1, but Not ATF Is an Adverse Prognostic Factor

Steven M. Kornblau, MD, Chenyue W Hu, Yihua Qiu, MD, Suk Young Yoo, PhD, Kavita Chauhan, Elias Jabbour, MD, Farhad Ravandi, MD, Kevin Coombes, PhD, Amina A Qutub, PhD

Blood (2014) 124 (21): 2344.

https://doi.org/10.1182/blood.V124.21.2344.2344

Published: 2014

Journal Articles

Heatshock Protein (HSP) Family Expression Is Dichotomous and Prognostic in Acute Myelogenous Leukemia (AML)

Steven M. Kornblau, MD, Chenyue W Hu, Yihua Qiu, MD, Suk Young Yoo, PhD, Trang T Nguyen, Tapan Kadia, MD, Gautam Borthakur, MD, Kevin Coombes, PhD, Amina A Qutub, PhD

Blood (2014) 124 (21): 1026.

https://doi.org/10.1182/blood.V124.21.1026.1026

Published: 2014

Journal Articles

MLN0128, a Second-Generation mTOR Kinase Inhibitor, Disrupts Survival Signaling and Triggers Apoptosis in AML

Zhihong Zeng, MD, Rui-Yu Wang, MD PhD, Yuexi Shi, MD, Yihua Qiu, MD, Duncan H Mak, MS, Kevin Coombes, PhD, Suk Young Yoo, PhD, Katti Jessen, Yi Liu, PhD, Christian Rommel, PhD, Hagop M. Kantarjian, MD, Steven M. Kornblau, MD, David Fruman, PhD, Michael Andreeff, MD PhD, Marina Konopleva, MD PhD

Blood (2014) 124 (21): 3613.

https://doi.org/10.1182/blood.V124.21.3613.3613

Published: 2014

Journal Articles

Expression of Ribosomal Protein S6 (R6SP) and Eukaryotic Translation Initiation Factor 4E Binding Protein 1 (EIF4EBP1) Is Correlated in Acute Myelogenous Leukemia (AML) and Is Highly Prognostic, Especially in NPM1 and FLT3 Wildtype Patients

Steven M. Kornblau, MD, Chenyue W Hu, Yihua Qiu, MD, Suk Young Yoo, PhD, Rebecca A Murray, Nitin Jain, MD, Yesid Alvarado, MD, Kevin Coombes, PhD, Amina A Qutub, PhD

Blood (2014) 124 (21): 2369.

https://doi.org/10.1182/blood.V124.21.2369.2369

Published: 2014

Journal Articles

Recurrent Patterns Of Histone Methylation and Acetylation Regulating Protein Expression In Acute Myelogenous Leukemia (AML)

Steven M. Kornblau, MD, Chenyu W Hu, Yihua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Amina A Qutub, PhD, Kevin R. Coombes, PhD

Blood (2013) 122 (21): 3733.

https://doi.org/10.1182/blood.V122.21.3733.3733

Published: 2013

Journal Articles

Hippo Pathway (HP) Activity In Acute Myelogenous Leukemia (AML): Different Prognostic Implications Of TAZ versus YAP Inactivation By Phosphorylation

Steven M. Kornblau, MD, Chenyu W Hu, Yi Hua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Tapan M. Kadia, MD, Alessandra Ferrajoli, MD, Kevin R. Coombes, PhD, Amina A Qutub, PhD

Blood (2013) 122 (21): 1337.

https://doi.org/10.1182/blood.V122.21.1337.1337

Published: 2013

Journal Articles

Survival Prediction In High Dimensional Datasets – Comparative Evaluation Of Lasso Regularization and Random Survival Forests

Erel Joffe, MD MSc, Kevin R. Coombes, PhD, Yi Hua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Elmer V Bernstam, MD MS, Steven M. Kornblau, MD

Blood (2013) 122 (21): 1728.

https://doi.org/10.1182/blood.V122.21.1728.1728

Published: 2013

Journal Articles

A Global Proteomic Pathway Map In Acute Myeloid Leukemia (AML)

Chenyu W Hu, Amina A Qutub, PhD, Yihua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Naveen Pammaraju, MD, Courtney D. DiNardo, MD, Kevin R. Coombes, PhD, Steven M. Kornblau, MD

Blood (2013) 122 (21): 1302.

https://doi.org/10.1182/blood.V122.21.1302.1302

Published: 2013

Journal Articles

Classification Of Acute Myelogenous Leukemia (AML) Based On Functionally Related Proteins Groups

Steven M. Kornblau, MD, Chenyu W Hu, Suk Young Yoo, PhD, Yihua Qiu, MD, Nianxiang Zhang, PhD, Gautam Borthakur, MD, Naval G. Daver, MD, Amina A Qutub, PhD, Kevin R. Coombes, PhD

Blood (2013) 122 (21): 492.

https://doi.org/10.1182/blood.V122.21.492.492

Published: 2013

Journal Articles

Proteomic Profiling of AML Bone Marrow-Derived Mesenchymal Stem Cells (MSC) Reveals Marked Differences From Normal MSC.

Rui-yu Wang, MD, PhD, Yi Hua Qiu, MD, Suk Young Yoo, PhD, Teresa McQueen, BS, Ye Chen, PhD, Zhihong Zeng, MD, Kevin R. Coombes, PhD, Wendy D. Schober, MLT (ASCP), Marina Konopleva, MD, PhD, Steven M. Kornblau, MD, PhD, Michael Andreeff, MD, PhD

Blood (2012) 120 (21): 2355.

https://doi.org/10.1182/blood.V120.21.2355.2355

Published: 2012

NARROW

FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B-cell acute leukemia

Recurrent Patterns of Protein Expression Signatures in Pediatric Acute Lymphoblastic Leukemia: Recognition and Therapeutic Guidance

Recognition of Recurrent Protein Expression Patterns in Pediatric Acute Myeloid Leukemia Suggests New Therapeutic Targets

Functional Proteomic Profiling of Myelodysplastic Syndromes Reveals Distinct Protein Expression Signatures and Identifies Candidate Therapeutic Targets

Role of Mesenchymal Stem Cell Galectin 3 in the AML Tumor Microenvironment

Acute Myelogenous Leukemia (AML) Mesenchymal Stromal Cell (MSC) Have Distinct Protein Expression Patterns Compared to Normal MSC

Adhesion Signaling States in AML

CREB/ATF Family Protein Expression States in AML: Active CREB1, but Not ATF Is an Adverse Prognostic Factor

Heatshock Protein (HSP) Family Expression Is Dichotomous and Prognostic in Acute Myelogenous Leukemia (AML)

MLN0128, a Second-Generation mTOR Kinase Inhibitor, Disrupts Survival Signaling and Triggers Apoptosis in AML

Expression of Ribosomal Protein S6 (R6SP) and Eukaryotic Translation Initiation Factor 4E Binding Protein 1 (EIF4EBP1) Is Correlated in Acute Myelogenous Leukemia (AML) and Is Highly Prognostic, Especially in NPM1 and FLT3 Wildtype Patients

Recurrent Patterns Of Histone Methylation and Acetylation Regulating Protein Expression In Acute Myelogenous Leukemia (AML)

Hippo Pathway (HP) Activity In Acute Myelogenous Leukemia (AML): Different Prognostic Implications Of TAZ versus YAP Inactivation By Phosphorylation

Survival Prediction In High Dimensional Datasets – Comparative Evaluation Of Lasso Regularization and Random Survival Forests

A Global Proteomic Pathway Map In Acute Myeloid Leukemia (AML)

Classification Of Acute Myelogenous Leukemia (AML) Based On Functionally Related Proteins Groups

Proteomic Profiling of AML Bone Marrow-Derived Mesenchymal Stem Cells (MSC) Reveals Marked Differences From Normal MSC.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only